PSMA-PET与传统影像对高危前列腺癌术前分期的比较:EAU-YAU多中心研究
该多中心回顾性研究纳入1475例接受前列腺根治术及扩大盆腔淋巴结清扫的高危前列腺癌患者,经倾向性评分匹配后比较PSMA-PET(miN0M0)与传统影像(cN0M0)对短期肿瘤学结局的影响;PSMA-PET组生化复发率更低,为独立预测因子。
要点
- PSMA-PET分期可降低高危前列腺癌术后生化复发风险。
- PSMA-PET组36个月无生化复发生存率高于传统影像组。
- 传统影像组中两个及以上高危特征与更差的无生化复发生存相关。
核心结论
- PSMA-PET分期组至生化复发时间长于传统影像分期组,更优的分期准确性可能改善高危前列腺癌术后短期肿瘤学结局。
研究设计与样本
- 多中心回顾性研究纳入2014至2024年间14家转诊中心接受前列腺根治术及扩大盆腔淋巴结清扫的1475例高危前列腺癌患者。
- 经标志点分析和1:1倾向性评分匹配(匹配年龄、手术年份、初始PSA、cT分期、活检ISUP分级分组)后,PSMA-PET组463例与传统影像组463例进行比较。
主要发现
- PSMA-PET组(miN0M0)PSA持续存在15例(3.2%),传统影像组(cN0M0)64例(14%),p < 0.001。
- 36个月无生化复发生存率在PSMA-PET组为90.9%,传统影像组为82.2%。
- 多因素Cox回归中,PSMA-PET是较低生化复发率的独立预测因子(风险比0.48;95%置信区间0.29-0.77;p = 0.003)。
- PSMA-PET组中一个高危特征与两个及以上高危特征患者的无生化复发生存率相似,而传统影像组中两个及以上高危特征与显著更差的无生化复发生存率相关。
临床怎么用
- 在高危前列腺癌术前分期中,优先采用PSMA-PET而非传统影像可能有助于改善术后短期生化复发结局。
局限性
- 研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Current guidelines strongly recommend prostate-specific membrane antigen positron emission tomography (PSMA-PET) for staging high-risk prostate cancer (PCa) patients. This study aims to evaluate the impact of staging procedure (PSMA-PET vs conventional imaging) on short-term oncologic outcomes in a cohort of N0M0 high-risk PCa patients who underwent radical prostatectomy (RP) and extended pelvic lymph node dissection (ePLND). METHODS: We retrospectively included 1475 high-risk PCa patients who underwent RP and ePLND in 14 referral centers between 2014 and 2024. Each patient underwent either PSMA-PET (miN0M0) or conventional imaging (cN0M0). After a landmark analysis and 1:1 propensity score matching for age at diagnosis, year of surgery, initial serum prostate-specific antigen (PSA), cT stage, and International Society of Urological Pathology grade group at biopsy, the Kaplan-Meier methodology was used to assess biochemical recurrence (BCR)-free survival (BCR-FS) and multivariable Cox regression models to identify the predictors of BCR (time in months between the date of RP and the date of BCR). KEY FINDINGS AND LIMITATIONS: After propensity score matching, 463 (48.2%) versus 463 (90.1%) patients underwent PSMA-PET versus conventional imaging. PSA persistence was observed in 15 (3.2%) versus 64 (14%) miN0M0 patients at PSMA-PET versus cN0M0 patients at conventional imaging (p < 0.001). The BCR-FS rates at 36 mo were 90.9% and 82.2% in the PSMA-PET and conventional imaging cohorts, respectively. At multivariate Cox regression analyses, PSMA-PET (hazard ratio: 0.48; 95% confidence interval: 0.29-0.77) was an independent predictor of lower BCR rates (p = 0.003). In the PSMA-PET cohort, BCR-FS rates were similar between patients with one high-risk feature and those with two or more high-risk features, while in the conventional imaging cohort, two or more high-risk features were associated with significantly worse BCR-FS rates than one high-risk feature. Limitations include the retrospective design of the study. CONCLUSIONS AND CLINICAL IMPLICATIONS: Time to biochemical recurrence was longer in the miN0M0 cohort than in the cN0M0 cohort. Superior PSMA-PET staging accuracy seems to improve short-term oncologic outcomes of high-risk PCa patients following surgery.
引用
- Bianchi L, Droghetti M, Catanzaro C, et al. Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Eur Urol Oncol. 2025. PMID: 41353037. doi:10.1016/j.euo.2025.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。